-
1 Comment
Wai Chun Bio-Technology Limited is currently in a long term downtrend where the price is trading 7.9% below its 200 day moving average.
From a valuation standpoint, the stock is 85.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.
Wai Chun Bio-Technology Limited's total revenue rose by 3.4% to $320M since the same quarter in the previous year.
Its net income has dropped by 745.6% to $-15M since the same quarter in the previous year.
Finally, its free cash flow grew by 241.2% to $12M since the same quarter in the previous year.
Based on the above factors, Wai Chun Bio-Technology Limited gets an overall score of 3/5.
| CurrencyCode | HKD |
|---|---|
| ISIN | KYG9450C1024 |
| Sector | Basic Materials |
| Industry | Chemicals |
| Exchange | HK |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Market Cap | 15M |
| Beta | -0.01 |
| Dividend Yield | None |
Wai Chun Bio-Technology Limited, an investment holding company, manufactures and sells modified starch and other biochemical products in the People's Republic of China. The company was formerly known as Wai Chun Mining Industry Group Company Limited and changed its name to Wai Chun Bio-Technology Limited in September 2019. Wai Chun Bio-Technology Limited was incorporated in 1992 and is headquartered in Wan Chai, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0660.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
